secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001628280-26-029812
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q1 revenue $76M, down 34% YoY; net loss $2.1M; guides Q2 revenue $60-80M
--------------------------------------------------------------------------------

- Revenue fell 34.3% to $76.0M; net loss widened to $2.1M ($0.19 EPS) from $0.8M loss.
- Active earning coaches dropped 44.9% to 14,000; rev per coach up 19.2% to $5,432.
- Gross margin 68.1% vs 72.8% a year ago; operating loss $3.3M vs $1.3M.
- Outlook: Q2 rev $60-80M, EPS loss $0.50-$1.00; FY rev $270-300M, EPS loss $1.55-$2.75.
- Cash $168.9M, no debt; expects active earning coaches to continue declining in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828026029812/0001628280-26-029812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828026029812/med-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-029812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer